FBTCX
Fidelity Advisor Biotechnology Cl C
$36.77
Fidelity Advisor Biotechnology Cl C (FBTCX) Holdings
- Holdings Count
- 78
- Total Assets
- 2.26B
- Top 10 Percentage
- 46.95%
Market Cap
Smart Score
Price Target Upside
Analyst Consensus
Yearly Gain
| Name | Market Value | Price & Change | Follow | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ABBVAbbvie | 14.71% | $323.68M | ― | $521.50B | 27.01% | Strong Buy | $312.43 | ||
| GILDGilead Sciences | 5.70% | $125.46M | ― | $208.48B | 34.25% | Strong Buy | $174.48 | ||
| SYRESpyre Therapeutics, Inc | 3.83% | $84.30M | ― | $9.88B | 359.57% | Strong Buy | $123.38 | ||
| ALNYAlnylam Pharmaceuticals | 3.62% | $79.57M | ― | $22.11B | -63.65% | Moderate Buy | $310.55 | ||
| DNTHDianthus Therapeutics, Inc. | 3.55% | $78.06M | ― | $5.17B | 158.62% | Strong Buy | $141.89 | ||
| COGTCogent Biosciences, Inc. | 3.25% | $71.43M | ― | $4.97B | -15.58% | Strong Buy | $54.88 | ||
| ORKAOruka Therapeutics, Inc. | 3.24% | $71.17M | ― | $7.15B | 299.36% | Strong Buy | $153.6 | ||
| INSMInsmed | 3.05% | $67.08M | ― | $26.58B | -36.55% | Strong Buy | $190.5 | ||
| RVMDRevolution Medicines, Inc. | 3.00% | $66.05M | ― | $37.27B | 167.61% | Strong Buy | $270.04 | ||
| ARGXArgenx | 3.00% | $65.91M | ― | $60.89B | 7.66% | Strong Buy | $1,175.05 |
Sector Breakdown
- Healthcare95.12%
- General4.88%
Countries Breakdown
- United States97.23%
- Belgium0.39%
Breakdown By Smart Score
The weighted average smart score of the FBTCX Mutual Fund is 6
- 1013.04%
- 97.64%
- 812.27%
- 79.05%
- 623.96%
- 510.94%
- 411.17%
- 35.57%
- 25.35%
- 11.00%
FBTCX Mutual Funds FAQ
What are Mutual Funds FBTCX’s top 3 holdings?
FBTCX’s top 3 holdings are ABBV, GILD, SYRE.
What is Mutual Funds FBTCX’s holdings count?
Mutual Funds FBTCX’s is holdings 78 different assets.
What are the total assets of Mutual Funds FBTCX?
Mutual Funds FBTCX’s total assets are 2.26B.

